Imran Hamid, MD
Education
Imperial College London
MBBS BSc(Hons), Medicine and Healthcare Management 1999-01-01 - 2005-01-01
The Royal College of Surgeons of England
MRCS, Surgery 2007-01-01 - 2008-01-01
Imperial Business School
BSc (Hons), Management 2003-01-01 - 2004-01-01
St Paul's School
, 1994-01-01 - 1999-01-01Work Experience
LifeArc Ventures
2021-10-01 - 2025-01-01
LifeArc Ventures
Cytospire Therapeutics Ltd
2023-11-01 - 2024-12-01
Cytospire Therapeutics Ltd
Affect
2023-06-01 - 2024-12-01
Affect
Ozlo
2022-10-01 - 2024-12-01
Ozlo
Surgery Hero
2022-09-01 - 2024-12-01
Surgery Hero
ikarovec
2022-05-01 - 2024-12-01
ikarovec
Closed Loop Medicine
2021-11-01 - 2023-10-01
Closed Loop Medicine
Cumulus Neuroscience
2022-02-01 - 2023-01-01
Cumulus Neuroscience
DJS Antibodies
2021-11-01 - 2022-11-01
DJS Antibodies
Johnson & Johnson
2019-02-01 - 2021-10-01
Johnson & Johnson
Skills
Summary
Imran is a medtech, healthtech and biotech investor and board member, with extensive experience in sourcing, executing and managing venture and growth stage investments, strategic partnerships, and acquisitions. Imran is a former surgeon, digital health entrepreneur, and corporate development professional. He has been integral to over $1.5bn venture, licensing, and M&A deals at digital health, med tech and biopharma companies including Merck, Mallinckrodt and J&J. Imran received his medical degree from Imperial College London, where he graduated with joint honours from the Imperial College Business School and is a member of the Royal College of Surgeons. He is committed to using his experiences to advance innovation to support the delivery of higher quality care and improve clinical outcomes.
